Trial Profile
Therapy of the Chronic Multiple Sclerosis With Interferon-beta 1a (Rebif).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Dec 2018
Price :
$35
*
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms REBIJECT-II
- Sponsors Merck KGaA
- 14 Jun 2010 New trial record